Other Species / Isoforms
  RARG (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R34
FAFPGALRGsPPFEM
0 3
RARG (human) FAFPGALRGsPPFEM R34
RARG iso2 (human) gap -
RARG (mouse) FAFPGALrGSPPFEM R34-m1
RARG iso2 (mouse) gap -
RARG (rat) FAFPGALRGSPPFEM R34
S36-p
FPGALRGsPPFEMLs
0 1
RARG (human) FPGALRGsPPFEMLs S36-p
RARG iso2 (human) gap -
RARG (mouse) FPGALrGSPPFEMLs S36
RARG iso2 (mouse) gap -
RARG (rat) FPGALRGSPPFEMLS S36
S43-p
sPPFEMLsPSFRGLG
Upstream
0 1
Treatment
  • ischemia
RARG (human) sPPFEMLsPSFRGLG S43-p
RARG iso2 (human) gap -
RARG (mouse) SPPFEMLsPSFRGLG S43-p
RARG iso2 (mouse) gap -
RARG (rat) SPPFEMLSPSFRGLG S43
S77-p
SEEMVPSsPsPPPPP
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • CDK7 (human)
  • GTF2F1 (human)
RARG (human) SEEMVPSsPsPPPPP S77-p
RARG iso2 (human) SEEMVPSsPsPPPPP S66-p
RARG (mouse) SEEMVPSsPsPPPPP S77-p
RARG iso2 (mouse) SEEMVPSsPsPPPPP S66-p
RARG (rat) SEEMVPSSPSPPPPP S77
S79-p
EMVPSsPsPPPPPRV
Upstream
Downstream
3 0
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • CDK7 (human)
  • ERK1 (human)
  • GTF2F1 (human)
Treatment
  • retinoic_acid
RARG (human) EMVPSsPsPPPPPRV S79-p
RARG iso2 (human) EMVPSsPsPPPPPRV S68-p
RARG (mouse) EMVPSsPsPPPPPRV S79-p
RARG iso2 (mouse) EMVPSsPsPPPPPRV S68-p
RARG (rat) EMVPSSPSPPPPPRV S79
K172-sm
NKKKKEVkEEGSPDS
0 1
RARG (human) NKKKKEVkEEGSPDS K172-sm
RARG iso2 (human) NKKKKEVKEEGSPDS K161
RARG (mouse) NKKKKEVKEEGSPDS K172
RARG iso2 (mouse) NKKKKEVKEEGSPDS K161
RARG (rat) NKKKKEVKEEGPPDN K172
K192-ub
QLEELITkVSKAHQE
0 1
RARG (human) QLEELITkVSKAHQE K192-ub
RARG iso2 (human) QLEELITKVSKAHQE K181
RARG (mouse) QLEELITKVSKAHQE K192
RARG iso2 (mouse) QLEELITKVSKAHQE K181
RARG (rat) QLEELITKVSKAHQE K192
S371-p
YARRRRPsQPYMFPR
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, induced
Putative in vivo kinases:
  • Akt1 (human)
Treatment
  • Akt_inhibitor_VIII
RARG (human) YARRRRPsQPYMFPR S371-p
RARG iso2 (human) YARRRRPSQPYMFPR S360
RARG (mouse) YARRRRPSQPYMFPR S371
RARG iso2 (mouse) YARRRRPsQPYMFPR S360-p
RARG (rat) YARRRRPSQPYMFPR S371
S390-p
ITDLRGIsTKGAERA
Downstream
1 0
Effects on Modified Protein
  • activity, induced
RARG (human) ITDLRGIsTKGAERA S390-p
RARG iso2 (human) ITDLRGISTKGAERA S379
RARG (mouse) ITDLRGIStKGAERA S390
RARG iso2 (mouse) ITDLRGIsTKGAERA S379-p
RARG (rat) ITDLRGISTKGAERA S390
T391
TDLRGIsTKGAERAI
0 1
RARG (human) TDLRGIsTKGAERAI T391
RARG iso2 (human) TDLRGISTKGAERAI T380
RARG (mouse) TDLRGIStKGAERAI T391-p
RARG iso2 (mouse) TDLRGIsTKGAERAI T380
RARG (rat) TDLRGISTKGAERAI T391
K447
EVPGGQGKGGLKsPA
0 22
RARG (human) EVPGGQGKGGLKsPA K447
RARG iso2 (human) EVPGGQGKGGLKSPA K436
RARG (mouse) EAPGGQGkRGQsPQP K447-ac
RARG iso2 (mouse) EAPGGQGkRGQSPQP K436-ac
RARG (rat) EAPGSQGKRGQSPQP K447
S452-p
QGKGGLKsPA_____
0 7
RARG (human) QGKGGLKsPA_____ S452-p
RARG iso2 (human) QGKGGLKSPA_____ S441
RARG (mouse) GQGkRGQsPQPDQGP S451-p
RARG iso2 (mouse) GQGkRGQSPQPDQGP S440
RARG (rat) SQGKRGQSPQPDQGP S451